ワクチンの世界市場販売分析:小児用ワクチン、成人用ワクチン、高齢者用ワクチン、トラベルワクチン、治療ワクチン...市場調査レポートについてご紹介

【英文タイトル】Vaccine Sales Analysis 2016-2026

▼当市場調査レポートの詳細内容確認、お問い合わせ及びご購入申込は下記ページでお願いします。▼マーケットレポート

【レポートの概要(一部)】

1. Report Overview
1.1 Overview of the World Vaccines Market
1.2 Why You Should Read This Report
1.3 How This Report Delivers
1.4 Main Questions Answered by This Analytical Study
1.5 Who is This Report For?
1.6 Methods of Research and Analysis
1.7 Frequently Asked Questions (FAQ)
1.8 Associated Visiongain Reports
1.9 About Visiongain

2. Introduction to the World Human Vaccines Market
2.1 Human Vaccines – Aiming for Global Disease Prevention
2.2 What is the Social and Economic Burden?
2.3 Vaccine Technology
2.3.1 Inactivated Vaccines
2.3.2 Live Attenuated Vaccines
2.3.3 Conjugate Vaccines
2.3.4 Recombinant Vector Vaccines
2.4 Key Influencers of the Human Vaccine Market
2.4.1 Governments and International Organizations
2.4.1.1 The World Health Organisation (WHO)
2.4.1.2 The Governmental Influence
2.4.2 Leading Manufacturers
2.4.2.1 Merck & Co.
2.4.2.2 Sanofi
2.4.2.3 GlaxoSmithKline
2.4.2.4 Pfizer
2.5 Human World Vaccines – Market Segmentation
2.5.1 Paediatric Vaccines
2.5.2 Adult Vaccines
2.5.3 Elderly Vaccines
2.5.4 Travel Vaccines
2.5.5 Therapeutic Vaccines

3. World Vaccine Market Outlook, 2016-2026
3.1 World Vaccine Market, 2015
3.1.1 Paediatric Vaccines Maintains Constant Demand
3.1.2 Ageing Population Requires More Care
3.1.3 Emerging Markets Demand Better Immunity
3.2 The World Human Vaccines Forecast, 2016-2026
3.3 The World Vaccine Market: Industry Trends, 2016-2026
3.3.1 Undulating Demand
3.3.2 Supply Restraints
3.3.3 Funding Trends
3.3.4 Protecting the Workforce of an Economy

4. World Vaccine Submarkets: Prospects, 2016-2026
4.1 Paediatric Vaccines
4.1.1 Paediatric Vaccine Forecast, 2016-2026
4.1.2 Paediatric Vaccine Trends
4.1.2.1 Innovative Delivery
4.1.2.2 Fear Factor
4.1.2.3 Novel Vectors
4.2 Adult Vaccines
4.2.1 Adult Vaccine Forecast, 2016-2026
4.2.2 Adult Vaccine Trends
4.2.2.1 Fighting the Flu
4.2.2.2 HPV
4.2.2.3 Repeat Doses for Continued Protection
4.3 Elderly Vaccines
4.3.1 Elderly Vaccine Forecast, 2016-2026
4.3.2 Elderly Vaccine Trends
4.3.2.1 With Age Comes Greater Risk
4.3.2.2 Ageing Population across the Globe
4.4 Travel Vaccines
4.4.1 Travel Vaccines Forecast, 2016-2026
4.4.2 Travel Vaccine Trends
4.4.2.1 Zika Virus Outbreak
4.4.2.2 Globalization Carries Diseases
4.5 Therapeutic Vaccines
4.5.1 Therapeutic Vaccine Trends

5. Leading Vaccines: Revenue Forecasts, 2016-2026
5.1 Prevnar – Pneumococcal Pneumonia
5.2 Gardasil – HPV
5.3 Fluzone – Influenza
5.4 Pentacel – DtaP, Polio, HiB
5.5 ProQuad / M-M-R II / Varivax – Varicella/Chickenpox, Measles, Mumps, Rubella.
5.6 Infanrix/Pediarix – Diptheria, Tetanus and Acellular Pertussis
5.7 Zostavax – Herpes
5.8 RotaTeq – Rotavirus
5.9 GSK Hepatitis Franchise – Hepatitis A & B
5.10 Menactra – Meningococcal

6. Leading Developed National Vaccines Markets, 2016-2026
6.1 The United States Vaccines Markets, 2016-2026
6.1.1 The US Vaccine Market, 2016
6.1.2 The US Vaccine Market Forecast, 2016-2026
6.2 Japanese Vaccines Market, 2016-2026
6.2.1 The Japanese Vaccine Market, 2016
6.2.2 The Japanese Vaccine Market Forecast, 2016-2026
6.2.3 Addressing the Alleged Vaccine Gap
6.3 EU5 Vaccine Market, 2016-2026
6.3.1 The EU5 Vaccine Market, 2016
6.3.2 The EU5 Vaccine Market Forecast, 2016-2026
6.4 United Kingdom Vaccine Market, 2016-2026
6.4.1 The UK Vaccine Market, 2016
6.4.2 The UK Vaccine Market Forecast, 2016-2026
6.5 France: Vaccine Market, 2016-2026
6.5.1 The French Vaccine Market, 2016
6.5.2 The French Vaccine Market Forecast, 2016-2026
6.5.3 French Healthcare System – Immunization Policy
6.6 Germany: Vaccine Market, 2016-2026
6.6.1 The German Vaccine Market, 2016
6.6.2 The German Vaccine Market Forecast, 2016-2026
6.7 Italy: Vaccine Market, 2016-2026
6.7.1 The Italian Vaccine Market, 2016
6.7.2 The Italian Vaccine Market Forecast, 2016-2026
6.7.3 Challenges in Public Healthcare
6.8 Spain: Vaccine Market 2016-2026
6.8.1 The Spanish Vaccine Market, 2016
6.8.2 The Spanish Vaccine Market Forecast, 2016-2026
6.8.3 District Rules – Economic Challenges

7. Leading Emerging National Markets, 2016-2026
7.1 China: Vaccine Market, 2016-2026
7.1.1 The Chinese Vaccine Market, 2016
7.1.2 The Chinese Vaccine Market Forecast, 2016-2026
7.1.3 Setting-Up Domestic Vaccine Industries
7.2 India: Vaccine Market, 2016-2026
7.2.1 The Indian Vaccine Market, 2016
7.2.2 The Indian Vaccine Market Forecast, 2016-2026
7.2.3 The Extent to which the Vaccine Market Can Flourish?
7.3 Brazil: Vaccine Market, 2016-2026
7.3.1 The Brazilian Vaccine Market, 2016
7.3.2 The Brazilian Vaccine Market Forecast, 2016-2026
7.3.3 Zika Outbreak
7.4 Russia: Vaccine Market, 2016-2026
7.4.1 The Russian Vaccine Market, 2016
7.4.2 The Russian Vaccine Market Forecast, 2016-2026
7.4.3 Power of the State

8. Leading Manufacturers of Vaccines for Human Use
8.1 GlaxoSmithKline (GSK)
8.1.1 GSK Vaccine Performance
8.1.2 GSK Developments
8.1.2.1 Mergers and Acquisitions
8.1.2.2 GSK Vaccine Pipeline
8.2 Merck & Co.
8.2.1 Merck Vaccine Performance
8.2.2 Merck Developments
8.2.2.1 Merck Market Movements
8.2.2.2 Collaborations
8.2.2.3 Merck Pipeline
8.3 Sanofi
8.3.1 Sanofi Vaccine Performance
8.3.2 Sanofi Developments
8.3.2.1 Mergers & Acquisitions
8.3.2.2 Sanofi Vaccine Pipeline
8.4 Pfizer
8.4.1 Pfizer Vaccine Performance
8.4.2 Pfizer Developments
8.4.2.1 Pfizer Mergers & Acquisitions
8.4.2.2 Pfizer Pipeline
8.5 Johnson & Johnson
8.6 AstraZeneca
8.7 Other Companies Serving the Vaccines Market

9. Research and Development, 2016
9.1 Prophylactic Vaccines R&D Pipeline
9.1.1 Paediatric Vaccines R&D Pipeline
9.1.2 Adult Vaccines R&D Pipeline
9.1.3 Elderly Vaccines R&D Pipeline
9.1.4 Travel Vaccines R&D Pipeline
9.2 Therapeutic Vaccines R&D Pipeline

10. Qualitative Analysis of the World Vaccines Market, 2016-2026
10.1 SWOT Analysis of the World Human Vaccines Market, 2016
10.1.1 Strengths
10.1.1.1 Ageing Population
10.1.1.2 Prevention is Better than Cure
10.1.1.3 Demand from Emerging Markets Continue
10.1.1.4 Promising R&D Pipeline
10.1.1.5 Increasing Awareness
10.1.2 Weaknesses
10.1.2.1 High Manufacturing Costs
10.1.2.2 Time Constraints
10.1.2.3 Barriers to Market Entry
10.1.3 Opportunities
10.1.3.1 Constant Improvements in Vaccine Technology and Delivery Methods
10.1.3.2 Shifting Focus on Adults Vaccines
10.1.4 Threats
10.1.4.1 Oligarchic Presence of Pharmaceutical Giants
10.1.4.2 Productivity Gap
10.2 STEP Analysis of the World Human Vaccines Industry and Market, 2016-2026
10.2.1 Social Factors
10.2.1.1 Maintaining a Healthier Workforce
10.2.1.2 Public Hesitation – Fear of Unwanted Side-Effects
10.2.2 Technological Forces
10.2.2.1 Evolution of Vaccine Technology Pave the Way for Prophylactics and Therapeutics
10.2.3 Economic Factors
10.2.3.1 High Costs of Production
10.2.3.2 Soaring Vaccines Demand from Developing Countries
10.2.4 Political Factors
10.2.4.1 Governments Play Crucial Roles in Vaccination

11. Conclusions
11.1 Segment Market Share Shift
11.2 Elderly People Become the New Target Market
11.3 Endemic Infections Drive Travel Vaccines Growth
11.4 Emerging Markets: High Demand for Vaccines
11.5 Demand in Mature Pharma Markets Continues: in Particular Japan Will Show Sales Growth
11.6 Strong and Diverse Research and Development
11.7 Concluding Remarks


【レポート販売概要】

■ タイトル:ワクチンの世界市場販売分析:小児用ワクチン、成人用ワクチン、高齢者用ワクチン、トラベルワクチン、治療ワクチン
■ 英文:Vaccine Sales Analysis 2016-2026
■ 発行日:2016年3月
■ 調査会社:visiongain
■ 商品コード:VGAIN6041535
■ 調査対象地域:グローバル
※当サイトは世界の市場調査レポート紹介サイトです。市場規模、市場動向、市場予測など、多様な分析データを含むグローバル調査レポートをご案内致します。日本国内を含むアジア太平洋、中国、ヨーロッパ、アメリカ、北米、中南米、中東、アフリカ地域などにおける、製品、サービス、技術、企業(メーカー、ベンダー)、市場シェア、市場環境など多様な項目に対応致します。当サイトでご紹介するレポートは「市場調査レポート販売サイトのMarketReport.jp」でお問い合わせ及びご購入可能です。